MetaADEDB 2.0 @ LMMD
Adderall
(PYHRZPFZZDCOPH-QXGOIDDHSA-N)
Structure
SMILES
OS(=O)(=O)O.C[C@@H](Cc1ccccc1)N.C[C@@H](Cc1ccccc1)N
Molecular Formula:
C18H28N2O4S
Molecular Weight:
368.491
Log P:
4.9812
Hydrogen Bond Acceptor:
6
Hydrogen Bond Donor:
4
TPSA:
135.02
CAS Number(s):
51-63-8
Synonym(s)
1.
Adderall
2.
Obetrol
External Link(s)
MeSHD003913
C090411
PubChem Compound25137958
5825
ChEBI51064
CHEMBLCHEMBL3544971
KEGGdr:D02078
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 328
Canada Vigilance: 1
Canada Vigilance
US FAERS
2Product substitution issueFAERS: 137
Canada Vigilance: 1
Canada Vigilance
US FAERS
3Product quality issueFAERS: 91US FAERS
4HeadacheFAERS: 76
Canada Vigilance: 1
Canada Vigilance
US FAERS
5FatigueFAERS: 59US FAERS
6Feeling abnormalFAERS: 40US FAERS
7SomnolenceFAERS: 40US FAERS
8NauseaFAERS: 36
Canada Vigilance: 1
Canada Vigilance
US FAERS
9AnxietyFAERS: 32US FAERS
10DizzinessFAERS: 29US FAERS
11MalaiseFAERS: 27US FAERS
12AgitationFAERS: 18US FAERS
13Product taste abnormalFAERS: 16US FAERS
14PalpitationsFAERS: 15US FAERS
15Drug dispensing errorFAERS: 14US FAERS
16Product physical issueFAERS: 14US FAERS
17TremorFAERS: 13US FAERS
18VomitingFAERS: 13US FAERS
19AstheniaFAERS: 12US FAERS
20Drug effect incompleteFAERS: 12US FAERS
21AngerFAERS: 11US FAERS
22LethargyFAERS: 10US FAERS
23PainFAERS: 10US FAERS
24Weight decreasedFAERS: 10US FAERS
25ConstipationFAERS: 9US FAERS
26CryingFAERS: 9US FAERS
27Product formulation issueFAERS: 9US FAERS
28Impaired work abilityFAERS: 8US FAERS
29Wrong technique in product usage processFAERS: 8US FAERS
30Abdominal discomfortFAERS: 7US FAERS
31Drug effect variableFAERS: 7US FAERS
32DyspepsiaFAERS: 7US FAERS
33HypersensitivityFAERS: 7US FAERS
34Adverse eventFAERS: 6US FAERS
35Depressed moodFAERS: 6US FAERS
36DysgeusiaFAERS: 6US FAERS
37Intentional product misuseFAERS: 6US FAERS
38Myocardial InfarctionFAERS: 6US FAERS
39PruritusFAERS: 6US FAERS
40AlopeciaFAERS: 5US FAERS
41Chest PainFAERS: 5US FAERS
42Chest discomfortFAERS: 5US FAERS
43Feeling jitteryFAERS: 5US FAERS
44Intentional product use issueFAERS: 5US FAERS
45Mood swingsFAERS: 5US FAERS
46MyalgiaFAERS: 5US FAERS
47Oropharyngeal painFAERS: 5US FAERS
48Suspected counterfeit productFAERS: 5US FAERS
49Therapeutic response changedFAERS: 5US FAERS
50Therapeutic response unexpected with drug substitutionFAERS: 5US FAERS
51UrticariaFAERS: 5US FAERS
52Abdominal PainFAERS: 4US FAERS
53BruxismFAERS: 4US FAERS
54DisorientationFAERS: 4US FAERS
55Drug DependenceFAERS: 4US FAERS
56FlatulenceFAERS: 4US FAERS
57Inappropriate schedule of drug administrationFAERS: 4US FAERS
58Panic DisorderFAERS: 4US FAERS
59ParanoiaFAERS: 4US FAERS
60Peripheral swellingFAERS: 4US FAERS
61Poor peripheral circulationFAERS: 4US FAERS
62Product availability issueFAERS: 4US FAERS
63Product counterfeitFAERS: 4US FAERS
64Product measured potency issueFAERS: 4US FAERS
65Product packaging quantity issueFAERS: 4US FAERS
66Product solubility abnormalFAERS: 4US FAERS
67Product use in unapproved indicationFAERS: 4US FAERS
68Therapy changeFAERS: 4US FAERS
69VertigoFAERS: 4US FAERS
70treatment failureFAERS: 4US FAERS
71ApathyFAERS: 3US FAERS
72ChillsFAERS: 3US FAERS
73Depressed Level of ConsciousnessFAERS: 3US FAERS
74DiscomfortFAERS: 3US FAERS
75Economic problemFAERS: 3US FAERS
76Educational problemFAERS: 3US FAERS
77FlushingFAERS: 3US FAERS
78HypersomniaFAERS: 3US FAERS
79Incorrect dose administeredFAERS: 3US FAERS
80InfluenzaFAERS: 3US FAERS
81Intentional drug misuseFAERS: 3US FAERS
82Medication ErrorFAERS: 3US FAERS
83Personality ChangeFAERS: 3US FAERS
84Product contaminationFAERS: 3US FAERS
85Product dispensing errorFAERS: 3US FAERS
86Product tamperingFAERS: 3US FAERS
87Product use issueFAERS: 3US FAERS
88TachycardiaFAERS: 3US FAERS
89Therapy non-responderFAERS: 3US FAERS
90Throat irritationFAERS: 3US FAERS
91Urinary IncontinenceFAERS: 3US FAERS
92Urinary hesitationFAERS: 3US FAERS
93Vitreous floatersFAERS: 3US FAERS
94Accidental exposure to product by childFAERS: 2US FAERS
95AcneFAERS: 2US FAERS
96Activities of daily living impairedFAERS: 2US FAERS
97Anaphylactic shockFAERS: 2US FAERS
98AnorexiaFAERS: 2US FAERS
99AsphyxiaFAERS: 2US FAERS
100AsthenopiaFAERS: 2US FAERS
101Bipolar DisorderFAERS: 2US FAERS
102Cerebrovascular accidentFAERS: 2US FAERS
103Change in sustained attentionFAERS: 2US FAERS
104Completed SuicideFAERS: 2US FAERS
105Disease recurrenceFAERS: 2US FAERS
106Drug ToleranceFAERS: 2US FAERS
107Drug abuseFAERS: 2US FAERS
108Drug dispensed to wrong patientFAERS: 2US FAERS
109Drug screen false positiveFAERS: 2US FAERS
110Drug screen negativeFAERS: 2US FAERS
111Drug screen positiveFAERS: 2US FAERS
112Dry skinFAERS: 2US FAERS
113DystoniaFAERS: 2US FAERS
114Emotional disorderFAERS: 2US FAERS
115Emotional povertyFAERS: 2US FAERS
116ErythemaFAERS: 2US FAERS
117FormicationFAERS: 2US FAERS
118Hormone level abnormalFAERS: 2US FAERS
119HostilityFAERS: 2US FAERS
120HungerFAERS: 2US FAERS
121Intercepted drug dispensing errorFAERS: 2US FAERS
122Joint swellingFAERS: 2US FAERS
123Maternal exposure during pregnancyFAERS: 2US FAERS
124Memory impairmentFAERS: 2US FAERS
125Muscle tightnessFAERS: 2US FAERS
126Musculoskeletal chest painFAERS: 2US FAERS
127Musculoskeletal stiffnessFAERS: 2US FAERS
128Neck PainFAERS: 2US FAERS
129OverdoseFAERS: 2US FAERS
130Pharmaceutical product complaintFAERS: 2US FAERS
131Product comminglingFAERS: 2US FAERS
132Product physical consistency issueFAERS: 2US FAERS
133Product shape issueFAERS: 2US FAERS
134Quality of life decreasedFAERS: 2US FAERS
135Reaction to drug excipientsFAERS: 2US FAERS
136RestlessnessFAERS: 2US FAERS
137RhabdomyolysisFAERS: 2US FAERS
138StomatitisFAERS: 2US FAERS
139StressFAERS: 2US FAERS
140SyncopeFAERS: 2US FAERS
141TachyphreniaFAERS: 2US FAERS
142Tardive DyskinesiaFAERS: 2US FAERS
143Therapeutic product effect decreasedFAERS: 2US FAERS
144Therapeutic product effect variableFAERS: 2US FAERS
145Therapy cessationFAERS: 2US FAERS
146TinnitusFAERS: 2US FAERS
147Unevaluable eventFAERS: 2US FAERS
148Visual ImpairmentFAERS: 2US FAERS
149White blood cell count decreasedFAERS: 2US FAERS
150Accidental exposure to productFAERS: 1US FAERS
151Accidental exposureFAERS: 1US FAERS
152Acute myocardial infarctionFAERS: 1US FAERS
153AgeusiaFAERS: 1US FAERS
154Altered state of consciousnessFAERS: 1US FAERS
155AmnesiaFAERS: 1US FAERS
156AnosmiaFAERS: 1US FAERS
157AphagiaFAERS: 1US FAERS
158ArthralgiaFAERS: 1US FAERS
159ArthritisFAERS: 1US FAERS
160AsthmaFAERS: 1US FAERS
161Atrial FibrillationFAERS: 1US FAERS
162Autonomic nervous system imbalanceFAERS: 1US FAERS
163Back PainFAERS: 1US FAERS
164BedriddenFAERS: 1US FAERS
165Bladder painFAERS: 1US FAERS
166Blood creatine phosphokinase increasedFAERS: 1US FAERS
167Blood glucose abnormalFAERS: 1US FAERS
168Blood potassium decreasedFAERS: 1US FAERS
169Blood pressure fluctuationFAERS: 1US FAERS
170Body temperature fluctuationFAERS: 1US FAERS
171Burning sensationFAERS: 1US FAERS
172Cardiac ArrestFAERS: 1US FAERS
173Cardiac FlutterFAERS: 1US FAERS
174Carpal Tunnel SyndromeFAERS: 1US FAERS
175ChokingFAERS: 1US FAERS
176Counterfeit drug administeredFAERS: 1US FAERS
177Counterfeit product administeredFAERS: 1US FAERS
178DehydrationFAERS: 1US FAERS
179DeliriumFAERS: 1US FAERS
180Dental cariesFAERS: 1US FAERS
181Disease complicationFAERS: 1US FAERS
182DissociationFAERS: 1US FAERS
183DiverticulitisFAERS: 1US FAERS
184Drug abuserFAERS: 1US FAERS
185Drug administration errorFAERS: 1US FAERS
186Drug effect delayedFAERS: 1US FAERS
187Drug ineffective for unapproved indicationFAERS: 1US FAERS
188Drug level changedFAERS: 1US FAERS
189Drug name confusionFAERS: 1US FAERS
190Drug titration errorFAERS: 1US FAERS
191Drug withdrawal syndromeFAERS: 1US FAERS
192Electrocardiogram abnormalFAERS: 1US FAERS
193Emotional distressFAERS: 1US FAERS
194EpilepsyFAERS: 1US FAERS
195EpistaxisFAERS: 1US FAERS
196Expired drug administeredFAERS: 1US FAERS
197Expired product administeredFAERS: 1US FAERS
198Extra dose administeredFAERS: 1US FAERS
199Eye painFAERS: 1US FAERS
200FrustrationFAERS: 1US FAERS
201General symptomFAERS: 1US FAERS
202Growth retardationFAERS: 1US FAERS
203HerniaFAERS: 1US FAERS
204HyperpyrexiaFAERS: 1US FAERS
205HypotensionFAERS: 1US FAERS
206Impaired driving abilityFAERS: 1US FAERS
207Inability to afford medicationFAERS: 1US FAERS
208IncontinenceFAERS: 1US FAERS
209Incorrect product storageFAERS: 1US FAERS
210InflammationFAERS: 1US FAERS
211Intentional dose omissionFAERS: 1US FAERS
212Intercepted product dispensing errorFAERS: 1US FAERS
213Intervertebral Disc DegenerationFAERS: 1US FAERS
214Joint Range of Motion DecreasedFAERS: 1US FAERS
215Joint stiffnessFAERS: 1US FAERS
216Limb discomfortFAERS: 1US FAERS
217Lip swellingFAERS: 1US FAERS
218Live BirthFAERS: 1US FAERS
219Loss of personal independence in daily activitiesFAERS: 1US FAERS
220MalabsorptionFAERS: 1US FAERS
221Manufacturing materials issueFAERS: 1US FAERS
222Medication residue presentFAERS: 1US FAERS
223Mental impairmentFAERS: 1US FAERS
224Mental status changesFAERS: 1US FAERS
225Muscle RigidityFAERS: 1US FAERS
226NarcolepsyFAERS: 1US FAERS
227NasopharyngitisFAERS: 1US FAERS
228NervousnessFAERS: 1US FAERS
229NeuralgiaFAERS: 1US FAERS
230Neutrophil percentage increasedFAERS: 1US FAERS
231No adverse eventFAERS: 1US FAERS
232Obsessive thoughtsFAERS: 1US FAERS
233Obsessive-Compulsive DisorderFAERS: 1US FAERS
234Ocular discomfortFAERS: 1US FAERS
235Oppositional Defiant DisorderFAERS: 1US FAERS
236Oral painFAERS: 1US FAERS
237Organic brain syndromeFAERS: 1US FAERS
238Paradoxical drug reactionFAERS: 1US FAERS
239Personal relationship issueFAERS: 1US FAERS
240Pharmaceutical product counterfeitFAERS: 1US FAERS
241Physical assaultFAERS: 1US FAERS
242PoisoningFAERS: 1US FAERS
243Poor quality sleepFAERS: 1US FAERS
244Post-Traumatic Stress DisorderFAERS: 1US FAERS
245PresyncopeFAERS: 1US FAERS
246Product coating issueFAERS: 1US FAERS
247Product complaintFAERS: 1US FAERS
248Product contamination chemicalFAERS: 1US FAERS
249Product dosage form issueFAERS: 1US FAERS
250Product label confusionFAERS: 1US FAERS
251Product lot number issueFAERS: 1US FAERS
252Product size issueFAERS: 1US FAERS
253Product storage errorFAERS: 1US FAERS
254Product use complaintFAERS: 1US FAERS
255Psychiatric symptomFAERS: 1US FAERS
256Restless Legs SyndromeFAERS: 1US FAERS
257RetchingFAERS: 1US FAERS
258RhinitisFAERS: 1US FAERS
259SchizophreniaFAERS: 1US FAERS
260Serotonin SyndromeFAERS: 1US FAERS
261SomnambulismFAERS: 1US FAERS
262StaringFAERS: 1US FAERS
263Sudden onset of sleepFAERS: 1US FAERS
264TrichorrhexisFAERS: 1US FAERS
265Unresponsive to stimuliFAERS: 1US FAERS
266Urinary tract infectionFAERS: 1US FAERS
267Wrong drug administeredFAERS: 1US FAERS
268Wrong patient received medicationFAERS: 1US FAERS
269YawningFAERS: 1US FAERS
270furuncleFAERS: 1US FAERS
271nervous system disorderFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.